News
Filters
Showing 1 - 10 out of 41 results
News
KSHB: Fentanyl Fight Sees Progress, But New Dangers Emerge for Young Children
Health care leaders and first responders gathered at Saint Luke's South Hospital to discuss ongoing efforts in the fight against fentanyl with U.S. Rep. Sharice Davids.
News
Physician's Weekly: Quality Improvement Initiative Ups Adherence to Medical Therapy for Heart Failure
A recent study led by Andrew Sauer, M.D., cardiologist at Saint Luke’s Mid America Heart Institute, showed that for patients with heart failure, hospital participation in the IMPLEMENT-HF initiative improves patient care.
Patient Stories
Second Opinion Means a Second Chance for Saint Luke’s Patient
After a fainting spell, Angela Alvarez was ultimately diagnosed with cardiomyopathy and congestive heart failure. Her original plan of action was to undergo a heart transplant, but she sought a second opinion at Saint Luke’s Mid America Heart Institute.
News
KCTV: Second Opinion From Saint Luke's Saves Man's Life After Put On Hospice at 52
A local man with heart failure who was told numerous times he only had months to live gets a second chance at life after treatment at Saint Luke's.
Patient Stories
Innovative Heart Failure Device Helps Lawrence Woman Return to Doing What She Loves
When Debbie O’Neal was diagnosed with heart failure at 75, she feared her life was ending. She was the same age that her mother had been when she died of heart disease.
News
USA Today: How to Reduce Your Risk of Heart Disease
Ahead of American Heart Month, USA Today talks with Dr. James O’Keefe of the Saint Luke’s Mid America Heart Institute about five steps you can take to reduce your risk of developing heart disease.
Article
Higher Omega-3 Levels Associated with Improved Cardiovascular Outcomes
According to a new study, higher omega-3 levels significantly reduce the risk of heart failure and heart failure fatalities.
News
Healio: Potassium Binder Helps Optimize Spironolactone Use in Patients with HF, Hyperkalemia Risk
A potassium binder helped patients with heart failure who have or are at high risk for hyperkalemia stay on spironolactone at an optimal dose, but showed a signal of HF hospitalization risk.
Article
Healio: Wegovy Improves Exercise Function in Obesity-Related Heart Failure with Concomitant Weight Loss
A secondary analysis of the pooled STEP-HFpEF and STEP-HFpEF DM trials showed the greatest improvements in those with the most weight loss at 52 weeks.
News
BBC News: Studies Reveal New Effects of Semaglutide
BBC News talked to Dr. Mikhail Kosiborod about new findings on the cardiovascular effects of semaglutide.